The ROE as of September 2024 (TTM) for Lipella Pharmaceuticals Inc. (LIPO) is -39095.64%

According to Lipella Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -39095.64%. This represents a change of 183.35% compared to the average of -13797.51% of the last 4 quarters.

Lipella Pharmaceuticals Inc. (LIPO) Historical ROE (quarterly & annually)

How has LIPO ROE performed in the past?

The mean historical ROE of Lipella Pharmaceuticals Inc. over the last ten years is -59.20%. The current -39095.64% ROE has changed 65.94% with respect to the historical average. Over the past ten years (40 quarters), LIPO's ROE was at its highest in in the September 2022 quarter at 1.14%. The ROE was at its lowest in in the June 2024 quarter at -55062.04%.

Lipella Pharmaceuticals Inc. (LIPO) ROE by Quarter and Year

Discovering the peaks and valleys of Lipella Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipella Pharmaceuticals Inc. (LIPO) Average ROE

How has LIPO ROE performed in the past?

The current ROE of Lipella Pharmaceuticals Inc. (LIPO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lipella Pharmaceuticals Inc. (LIPO) ROE vs. Peers

How is LIPO’s ROE compared to its peers?

Lipella Pharmaceuticals Inc.’s ROE is less than Senti Biosciences, Inc. (-91.09%), less than Fennec Pharmaceuticals Inc. (-52.10%), less than Monopar Therapeutics Inc. (-110.60%), less than Applied Molecular Transport Inc. (-218.56%), less than Adynxx, Inc. (0%), less than Ascletis Pharma Inc. (0%), less than Eupraxia Pharmaceuticals Inc. (-0.82%), less than AVAX Technologies, Inc. (-198.59%), less than Transgene SA (-344.15%), less than Alpha Cognition Inc. (-178.29%), less than ImmuCell Corporation (537.50%), less than Anebulo Pharmaceuticals, Inc. (-16.35%), less than NervGen Pharma Corp. (-122.97%), less than Acrivon Therapeutics, Inc. Common Stock (-267.77%), less than Protagenic Therapeutics, Inc. (-47.31%), less than Miromatrix Medical Inc. (-238.37%), less than Eliem Therapeutics, Inc. (-119.21%), less than Inhibrx, Inc. (-47.03%), less than Merrimack Pharmaceuticals, Inc. (1.62%), less than Celcuity Inc. (-35.28%), less than Enliven Therapeutics, Inc. (-60.83%), less than null (-29.31%),

Build a custom stock screener for Lipella Pharmaceuticals Inc. (LIPO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipella Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipella Pharmaceuticals Inc. (LIPO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipella Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.